BE-26263
BE-26263, an antiosteoporotic agent that can be isolated from Scedosporium apiospermum, possesses estrogenic effect[1].
Product Specifications
CAS Number
147716-81-2
UNSPSC
12352005
Target
Estrogen Receptor/ERR
Type
Natural Products
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology; Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/be-26263.html
Solubility
10 mM in DMSO
Smiles
OC1=C(C(OC(CC(OC(CC2=CC(O)=CC(O)=C2C3=O)C)=O)C)=O)C(CC(OC(CC(OC(CC(O3)C)=O)C)=O)C)=CC(O)=C1
Molecular Formula
C32H38O14
Molecular Weight
646.64
References & Citations
[1]Jpn Kokai Tokkyo Koho, et al. Estrogenic BE-26263 and its manufacture with Scedosporium apiospermum. Patent JP 05032658.|[2]Rakesh Maurya, et al. Antiosteoporotic Agents From Natural Sources. Studies in Natural Products Chemistry Volume 35, 2008, Pages 517-548.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb3097204 100 µg
Band 4.1-like protein 5 EPB41L5 Rabbit Polyclonal Antibody (Fluoro550)
Sign In for Pricing
View Details 